Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.25 USD
66.67%
Updated:
May 17, 2024
Sonoma Pharmaceuticals Inc
Other Current Liabilities
|
Sonoma Pharmaceuticals Inc
Other Current Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Other Current Liabilities
$138k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-26%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Current Liabilities
$3.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
17%
|
CAGR 10-Years
14%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Current Liabilities
$6.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
32%
|
CAGR 10-Years
13%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Current Liabilities
$28B
|
CAGR 3-Years
20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Current Liabilities
$5.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
17%
|
CAGR 10-Years
7%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Current Liabilities
$4.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
See Also
What is Sonoma Pharmaceuticals Inc's Other Current Liabilities?
Other Current Liabilities
138k
USD
138k
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Other Current Liabilities amounts to 138k USD.
What is Sonoma Pharmaceuticals Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-26%
-26%
Over the last year, the Other Current Liabilities growth was -14%. The average annual Other Current Liabilities growth rates for Sonoma Pharmaceuticals Inc have been -12% over the past three years , -23% over the past five years , and -26% over the past ten years .
You don't have any saved screeners yet
